The top 10 key targets of DHGC in the treatment of AKI were identified as ESR1, AR, PPARG, ESR2, GSK3β, PRSS1, NCOA2, SIRT3, PTGS1, and ACHE. Here, PRSS1 is linked to acute kidney injury.